SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-076674
Filing Date
2023-03-22
Accepted
2023-03-22 16:04:53
Documents
51
Period of Report
2023-03-22
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d485707d8k.htm   iXBRL 8-K 26903
2 EX-99.1 d485707dex991.htm EX-99.1 36907
6 GRAPHIC g485707ex99_1p10g1.jpg GRAPHIC 221101
7 GRAPHIC g485707ex99_1p11g1.jpg GRAPHIC 391473
8 GRAPHIC g485707ex99_1p12g1.jpg GRAPHIC 268016
9 GRAPHIC g485707ex99_1p13g1.jpg GRAPHIC 316259
10 GRAPHIC g485707ex99_1p14g1.jpg GRAPHIC 261566
11 GRAPHIC g485707ex99_1p15g1.jpg GRAPHIC 311670
12 GRAPHIC g485707ex99_1p16g1.jpg GRAPHIC 247394
13 GRAPHIC g485707ex99_1p17g1.jpg GRAPHIC 253862
14 GRAPHIC g485707ex99_1p18g1.jpg GRAPHIC 198309
15 GRAPHIC g485707ex99_1p19g1.jpg GRAPHIC 316612
16 GRAPHIC g485707ex99_1p1g1.jpg GRAPHIC 346515
17 GRAPHIC g485707ex99_1p20g1.jpg GRAPHIC 299883
18 GRAPHIC g485707ex99_1p21g1.jpg GRAPHIC 260410
19 GRAPHIC g485707ex99_1p22g1.jpg GRAPHIC 270767
20 GRAPHIC g485707ex99_1p23g1.jpg GRAPHIC 317120
21 GRAPHIC g485707ex99_1p24g1.jpg GRAPHIC 281799
22 GRAPHIC g485707ex99_1p25g1.jpg GRAPHIC 352561
23 GRAPHIC g485707ex99_1p26g1.jpg GRAPHIC 334313
24 GRAPHIC g485707ex99_1p27g1.jpg GRAPHIC 272917
25 GRAPHIC g485707ex99_1p28g1.jpg GRAPHIC 385869
26 GRAPHIC g485707ex99_1p29g1.jpg GRAPHIC 326728
27 GRAPHIC g485707ex99_1p2g1.jpg GRAPHIC 551699
28 GRAPHIC g485707ex99_1p30g1.jpg GRAPHIC 267509
29 GRAPHIC g485707ex99_1p31g1.jpg GRAPHIC 343301
30 GRAPHIC g485707ex99_1p32g1.jpg GRAPHIC 235694
31 GRAPHIC g485707ex99_1p33g1.jpg GRAPHIC 318316
32 GRAPHIC g485707ex99_1p34g1.jpg GRAPHIC 265313
33 GRAPHIC g485707ex99_1p35g1.jpg GRAPHIC 190628
34 GRAPHIC g485707ex99_1p36g1.jpg GRAPHIC 262566
35 GRAPHIC g485707ex99_1p37g1.jpg GRAPHIC 353116
36 GRAPHIC g485707ex99_1p38g1.jpg GRAPHIC 385782
37 GRAPHIC g485707ex99_1p3g1.jpg GRAPHIC 382820
38 GRAPHIC g485707ex99_1p4g1.jpg GRAPHIC 378862
39 GRAPHIC g485707ex99_1p5g1.jpg GRAPHIC 290593
40 GRAPHIC g485707ex99_1p6g1.jpg GRAPHIC 293071
41 GRAPHIC g485707ex99_1p7g1.jpg GRAPHIC 249854
42 GRAPHIC g485707ex99_1p8g1.jpg GRAPHIC 170019
43 GRAPHIC g485707ex99_1p9g1.jpg GRAPHIC 321864
  Complete submission text file 0001193125-23-076674.txt   16040490

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ikt-20230322.xsd EX-101.SCH 2824
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ikt-20230322_lab.xml EX-101.LAB 18738
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ikt-20230322_pre.xml EX-101.PRE 11691
45 EXTRACTED XBRL INSTANCE DOCUMENT d485707d8k_htm.xml XML 3469
Mailing Address 3350 RIVERWOOD PARKWAY SE, SUITE 1900 ATLANTA GA 30339
Business Address 3350 RIVERWOOD PARKWAY SE, SUITE 1900 ATLANTA GA 30339 678-392-3419
Inhibikase Therapeutics, Inc. (Filer) CIK: 0001750149 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39676 | Film No.: 23752925
SIC: 2836 Biological Products, (No Diagnostic Substances)